Exploratory Analysis of Front-Line Therapies in REVEL: a Randomised Phase 3 Study of Ramucirumab Plus Docetaxel Versus Docetaxel for the Treatment of Stage IV Non-Small-cell Lung Cancer after Disease Progression on Platinum-Based Therapy
ESMO OPEN（2020）
关键词
metastatic,non-squamous,squamous,vascular endothelial growth factor receptor,chemotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要